Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

ClinicalTrials.gov ID: NCT01998633

Public ClinicalTrials.gov record NCT01998633. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 1:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Reduced-Intensity Conditioning for Children and Adults With Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (RICHI) (BMT CTN #1204)

Study identification

NCT ID: NCT01998633
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Medical College of Wisconsin; Other
Enrollment: 47 participants

Conditions and interventions

Conditions

Interventions

Hematopoietic Stem Cell Transplant Biological

Biological

Eligibility (public fields only)

Age range: 4 Months to 45 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2013
Primary completion: Sep 22, 2016
Completion: Nov 30, 2016
Last update posted: Dec 7, 2022

2013 – 2016

United States locations

U.S. sites: 19
U.S. states: 15
U.S. cities: 19

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35294	—
Children's National Medical Center	Washington D.C.	District of Columbia	20010	—
Children's Healthcare of Atlanta	Atlanta	Georgia	30322	—
Ann and Robert H. Lurie Children's Hospital of Chicago	Chicago	Illinois	60614-3363	—
Johns Hopkins	Baltimore	Maryland	21231	—
Dana Farber Cancer Institute/Children's Hospital of Boston	Boston	Massachusetts	02215	—
University of Michigan Medical Center	Ann Arbor	Michigan	48105-2967	—
Washington University/St. Louis Children's Hospital	St Louis	Missouri	63110	—
Memorial Sloan-Kettering Cancer Center	New York	New York	10065	—
University of Rochester Medical Center	Rochester	New York	14642	—
University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27599-7305	—
Duke University Medical Center	Durham	North Carolina	27705	—
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229-3039	—
Oregon Health and Science University	Portland	Oregon	97239-3098	—
Children's Medical Center of Dallas	Dallas	Texas	75235	—
Cook Children's Medical Center	Fort Worth	Texas	76104	—
Baylor College of Medicine	Houston	Texas	77030	—
Fred Hutchinson Cancer Research Center	Seattle	Washington	98109-1024	—
Midwest Children's Cancer	Milwaukee	Wisconsin	53211	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01998633, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 7, 2022 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01998633 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →